28-Aug-2026
Business Wire (Sat, 29-Aug 7:41 AM ET)
Globe Newswire (Fri, 14-Aug 8:00 AM ET)
Globe Newswire (Tue, 11-Aug 9:16 AM ET)
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
PRNewswire (Fri, 7-Aug 2:16 PM ET)
Business Wire (Fri, 7-Aug 11:02 AM ET)
Lantheus Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 6-Aug 7:00 AM ET)
Globe Newswire (Tue, 4-Aug 2:11 PM ET)
PRNewswire (Mon, 3-Aug 3:23 PM ET)
Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 3-Aug 1:41 PM ET)
PRNewswire (Mon, 3-Aug 11:13 AM ET)
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Lantheus Holdings trades on the NASDAQ stock market under the symbol LNTH.
As of August 28, 2026, LNTH stock price climbed to $100.77 with 1,087,430 million shares trading.
LNTH has a beta of 0.45, meaning it tends to be less sensitive to market movements. LNTH has a correlation of 0.03 to the broad based SPY ETF.
LNTH has a market cap of $6.58 billion. This is considered a Mid Cap stock.
Last quarter Lantheus Holdings reported $388 million in Revenue and $1.55 earnings per share. This beat revenue expectation by $24 million and exceeded earnings estimates by $.29.
In the last 3 years, LNTH traded as high as $126.89 and as low as $47.25.
The top ETF exchange traded funds that LNTH belongs to (by Net Assets): AVUV, IJH, VTI, IWM, VB.
LNTH has outperformed the market in the last year with a price return of +81.6% while the SPY ETF gained +19.7%. However, in the short term, LNTH had mixed performance relative to the market. It has underperformed in the last 3 months, returning +1.2% vs +2.2% return in SPY. But in the last 2 weeks, LNTH shares have fared better than the market returning -0.2% compared to SPY -0.9%.
LNTH support price is $99.58 and resistance is $101.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LNTH shares will trade within this expected range on the day.